Others.


Last updated: 2021 Sep 13
Total hit(s): 8
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
The D614G spike mutation results in increased viral transduction. However, there was no change in the binding profiles of soluble D614 and G614 spike to human ACE2. The two dissociation constants (KD) were: KD1 = 8.45 nM and KD2 = 127 nM for D614 variant, and KD1 = 18.0 nM and KD2 = 92.7 nM for G614 variant.
32587969
(bioRxiv)
PMID
32587969
Date of Publishing: 2020 Jun 15
Title The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types
Author(s) name Daniloski Z, Guo X, Sanjana NE.
Journal bioRxiv
Impact factor
Its not a journal
Citation count: 2
Date of Entry 2021 Sep 13


Structure analysis of SARS-CoV-2 N439K Receptor Binding Domain (RBD) in complex with hACE2 at 2.8 resolution showed strong non-covalent salt bridges. These bridges enhanced the binding for hACE2 in the N439K variant, as similar to the SARS-CoV N439R variant. Double mutants of N439K/R and K417V mutations show that salt bridge loss at RBD position 417 is compensated by the one at position 439. This results in hACE2 affinity similar to the wild type. Methods used for study: X-ray structure, Surface plasmon resonance (SPR)
33621484
(Cell)
PMID
33621484
Date of Publishing: 2021 Jan 28
Title Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Author(s) nameThomson EC, Rosen LE et al.
Journal Cell
Impact factor
27.35
Citation count: 1
Date of Entry 2021 Aug 6


The binding kinetics of the spike protein of alpha variant and spike of the D614G variant was compared by biolayer interferometry (BLI). A 2-fold decrease was observed in the dissociation constant (Kd) of spike in the alpha variant (Kd=1.3nM) compared to the D614G variant (Kd=3.1nM).
-
()
PMID
-
Title Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutations
Date of Entry 2021 Aug 6


The Y453F and L452R mutations significantly increased the binding affinity to human ACE2 (RBD parental KD = 2.05 0.26 nM; RBD Y453F KD = 0.51 0.06 nM; RBD L452R KD = 1.20 0.06 nM)
-
()
PMID
-
Title An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
Date of Entry 2021 Aug 6


A multiplex RT-qPCR assay was designed to identify and differentiate between the B.1.1.7 and the B.1.351 variants. The assay can detect the B.1.1.7 specific D3L mutation and the B.1.351 specific 242-244 deletion mutation. This assay can be used for the rapid and precise differentiation of the alpha and beta variants
-
()
PMID
-
Date of Publishing: 2021 May 22
Title Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants-Alpha (B.1.1.7) and Beta (B.1.351)
Date of Entry 18_40_00 Jul


Xenonucleic acids (XNA)-based multiplex qPCR testing kit was developed to detect the SARS CoV-2 variants. The kit helps in identifying the D614G mutation and N501Y mutations in SARS-CoV-2. Owing to the stronger hybridization of XNA/DNA than DNA, XNAs are used to target specific nucleic sequences allowing for more accurate and robust results. DG614 variant (B.1.1.7) is now prevalent in the United States due to its higher transmissibility and infective rates than expected. N501Y variant belonging to the clade of the former has independently developed in the UK and has the potential to emerge as the dominant variant.
-
()
PMID
-
Date of Publishing: 2021 Apr 05
Title A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR
Date of Entry 18_40_00 Jul


There were no changes in the symptoms or duration of the disease in cases associated with the SARS-CoV-2 Alpha variant. Vaccines were likely to remain effective against the Alpha variant owing to no changes in the reinfection rates.
-
()
PMID
-
Date of Publishing: 2021 Apr 12
Title Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Date of Entry 18_28_28 Jul


The most common symptoms associated with the SARS-CoV-2 Alpha variant was Sore throat, Myalgia, and Fatigue.
-
()
PMID
-
Date of Publishing: 2021 Jan 27
Title Covid-19: Sore throat, fatigue, and myalgia are more common with new UK variant
Date of Entry 18_28_28 Jul